FDA Drug Recalls

Recalls / Class II

Class IID-0145-2020

Product

Pantoprazole Sodium Delayed Release Tablets, USP, 40 mg, packaged in 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd, Roorkee - 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-284-90

Affected lot / code info
Lot # PA218P008, PA218P009, Exp 04/2021

Why it was recalled

CGMP Deviation: Presence of dark brown discoloration on edges of tablets.

Recalling firm

Firm
Jubilant Cadista Pharmaceuticals, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
207 Kiley Dr, N/A, Salisbury, Maryland 21801-2249

Distribution

Quantity
63,216 bottles
Distribution pattern
Product was distributed to MS, OH, RI, TN and Puerto Rico to distributors and wholesalers who may have further distributed the product to the retail level.

Timeline

Recall initiated
2019-09-04
FDA classified
2019-10-17
Posted by FDA
2019-10-23
Terminated
2020-02-12
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0145-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.